Commonwealth Retirement Investments LLC Acquires New Shares in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Commonwealth Retirement Investments LLC acquired a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,849 shares of the company’s stock, valued at approximately $401,000. Commonwealth Retirement Investments LLC owned 0.14% of Invesco Pharmaceuticals ETF at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PJP. JPMorgan Chase & Co. lifted its position in shares of Invesco Pharmaceuticals ETF by 241.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock worth $352,000 after purchasing an additional 2,862 shares during the period. FMR LLC raised its stake in Invesco Pharmaceuticals ETF by 29.4% in the third quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after buying an additional 240 shares in the last quarter. Jane Street Group LLC purchased a new stake in Invesco Pharmaceuticals ETF during the third quarter worth $1,163,000. Arete Wealth Advisors LLC bought a new stake in Invesco Pharmaceuticals ETF during the 3rd quarter valued at $402,000. Finally, MGB Wealth Management LLC increased its holdings in shares of Invesco Pharmaceuticals ETF by 11.9% in the 4th quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock valued at $1,815,000 after acquiring an additional 2,345 shares during the period.

Invesco Pharmaceuticals ETF Trading Up 0.1 %

PJP opened at $86.66 on Tuesday. The firm has a market cap of $264.31 million, a price-to-earnings ratio of 24.54 and a beta of 0.58. Invesco Pharmaceuticals ETF has a 12 month low of $75.33 and a 12 month high of $89.87. The stock has a fifty day moving average price of $84.40 and a 200-day moving average price of $85.92.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.